Health Condition 1: J219- Acute bronchiolitis, unspecified
Conditions
Interventions
Intervention1: Nebulised N-Acetylcysteine: 2 ML 8 hourly along with
standard supportive care
Control Intervention1: Nebulisation of 3%
Hypertonicsaline: 2 ML 8 hourly
along with standard supportiv
Sponsors
Government Institute of Medical Sciences Greater Noida
Eligibility
Inclusion criteria
Inclusion criteria: parents have provided consent for their participation in the study with diagnosis of Bronchiolitis hospitalized in NICU or PICU or ward and a clinical severity score of more than 4 on presentation
Exclusion criteria
Exclusion criteria: Patients affecting with: 1. congenital cardiac diseases 2.anatomical pulmonary defects 3.bronchopulmonary dysplasia 4.chronic lung disease 5.neuromuscular impairment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the change in pre and post clinical severity scores in patients with bronchiolitis receiving nebulised N-Acetylcysteine versus Nebulised 3%Hypertonic SalineTimepoint: From Baseline to end of study at day 5 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To compare the duration of hospitalization in both the groups. 2.To compare the duration of ventilation or oxygen support if required among both the groups Timepoint: From Baseline to end of study at day 5 | — |
Countries
India
Contacts
Public ContactDr Aarti
Government Institute of Medical Sciences
Outcome results
None listed